Chan H. Park

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 38 publications

ASO Visual Abstract: Risk of pN2/3 Understaging in Sentinel Node-Positive ER+/HER2- Breast Cancer: A Composite Clinicopathologic Score for Safe RxPONDER and MonarchE Application.

ASO Visual Abstract: Risk of pN2/3 Understaging in Sentinel Node-Positive ER+/HER2- Breast Cancer: A Composite Clinicopathologic Score for Safe RxPONDER and MonarchE Application.

Journal: Annals of surgical oncology
Published: July 31, 2026

Risk of pN2/3 Understaging in Sentinel Node-Positive ER+/HER2- Breast Cancer: A Composite Clinicopathologic Score for Safe RxPONDER and MonarchE Application.

Risk of pN2/3 Understaging in Sentinel Node-Positive ER+/HER2- Breast Cancer: A Composite Clinicopathologic Score for Safe RxPONDER and MonarchE Application.

Journal: Annals of surgical oncology
Published: April 24, 2026

Impact of residual microcalcifcations on prognosis after neoadjuvant chemotherapy in breast cancer patients.

Impact of residual microcalcifcations on prognosis after neoadjuvant chemotherapy in breast cancer patients.

Journal: BMC women's health
Published: June 29, 2023

Association between skeletal muscle mass and mammographic breast density.

Association between skeletal muscle mass and mammographic breast density.

Journal: Scientific reports
Published: February 05, 2021

Menopausal Transition, Body Mass Index, and Prevalence of Mammographic Dense Breasts in Middle-Aged Women.

Menopausal Transition, Body Mass Index, and Prevalence of Mammographic Dense Breasts in Middle-Aged Women.

Journal: Journal of clinical medicine
Published: June 25, 2020

Mammographic breast density, its changes, and breast cancer risk in premenopausal and postmenopausal women.

Mammographic breast density, its changes, and breast cancer risk in premenopausal and postmenopausal women.

Journal: Cancer
Published: May 21, 2020

Optimal treatment of breast cancer in women older than 75 years: a Korea Breast Cancer Registry analysis.

Optimal treatment of breast cancer in women older than 75 years: a Korea Breast Cancer Registry analysis.

Journal: Breast cancer research and treatment
Published: August 17, 2019

Predictive factors for the presence of invasive components in patients diagnosed with ductal carcinoma in situ based on preoperative biopsy.

Predictive factors for the presence of invasive components in patients diagnosed with ductal carcinoma in situ based on preoperative biopsy.

Journal: BMC cancer
Published: August 08, 2019

Contrast enhanced digital mammography versus magnetic resonance imaging for accurate measurement of the size of breast cancer.

Contrast enhanced digital mammography versus magnetic resonance imaging for accurate measurement of the size of breast cancer.

Journal: The British journal of radiology
Published: April 25, 2019

Serum concentration of thyroid hormones in abnormal and euthyroid ranges and breast cancer risk: A cohort study.

Serum concentration of thyroid hormones in abnormal and euthyroid ranges and breast cancer risk: A cohort study.

Journal: International journal of cancer
Published: October 16, 2018

Diagnostic Value of Contrast-Enhanced Digital Mammography versus Contrast-Enhanced Magnetic Resonance Imaging for the Preoperative Evaluation of Breast Cancer.

Diagnostic Value of Contrast-Enhanced Digital Mammography versus Contrast-Enhanced Magnetic Resonance Imaging for the Preoperative Evaluation of Breast Cancer.

Journal: Journal of breast cancer
Published: July 11, 2018

Chronologically changing patterns in the survival of korean patients with breast cancer and related clinical factors: a nationwide registry-based study.

Chronologically changing patterns in the survival of korean patients with breast cancer and related clinical factors: a nationwide registry-based study.

Journal: Breast cancer research and treatment
Published: July 10, 2018
Showing 1-12 of 38

Last Updated: 09/26/2026